GU Oncology Medical Science Liaison — Field Leader

Johnson & Johnson Innovative Medicine; Indianapolis (IN); Hybrid; USD 120.000 - 190.000; Vollzeit

Zusammenfassung

Johnson & Johnson Innovative Medicine is recruiting a Medical Science Liaison - GU Oncology to be based in the Southern Indiana and Western Kentucky territory. The MSL acts as the field-based scientific expert, developing professional relationships with KOLs and health care professionals, and providing balanced, non-promotional scientific information.

The MSL will drive high-quality scientific exchange, stay current with treatment trends, and support investigator-initiated studies while

Qualifikationen

• Doctorate level degree or equivalent (PharmD, PhD, MD, advanced practice).
• 2+ years of relevant MSL/therapeutic area experience preferred.
• Must hold a valid US driver’s license.

Aufgaben

• Develop and implement a scientific engagement plan for the territory.
• Cultivate relationships with community and academic opinion leaders/KOLs to advance scientific credibility.
• Engage in high-quality two-way scientific exchange with healthcare professionals.
• Provide product and technical assistance and educational training during in-room clinical support.
• Leverage AI tools to enhance decision making, streamline processes, and improve outcomes.
• Maintain awareness of competitors and provide evidence-based clinical context.
• Deliver scientific data tailored to HCP needs through clear dialogue and presentations.
• Engage healthcare providers and internal partners to identify challenges and propose educational initiatives.

Kenntnisse

Scientific acumen

Data analysis

Cross-functional collaboration

Healthcare knowledge

Territory travel

Ausbildung

Doctorate or equivalent

Jobbeschreibung

Johnson & Johnson Innovative Medicine is recruiting a Medical Science Liaison - GU Oncology to be based in the Southern Indiana and Western Kentucky territory. The MSL acts as the field-based scientific expert, developing professional relationships with KOLs and health care professionals, and providing balanced, non-promotional scientific information.

The MSL will drive high-quality scientific exchange, stay current with treatment trends, and support investigator-initiated studies while